Cytokinetics, Inc. (CYTK)
60.06
+0.06
(+0.10%)
USD |
NASDAQ |
Mar 13, 16:00
60.07
+0.01
(+0.02%)
After-Hours: 20:00
Cytokinetics Shareholders Equity (Quarterly) : -659.62M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 18.47B |
| Lifecore Biomedical, Inc. | 36.79M |
| Molina Healthcare, Inc. | 4.069B |
| Corcept Therapeutics, Inc. | 647.80M |
| Ionis Pharmaceuticals, Inc. | 489.09M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.425B |
| Total Liabilities (Quarterly) | 2.084B |
| Debt to Equity Ratio | -1.947 |
| Current Ratio | 4.529 |
| Net Debt Paydown Yield | -1.27% |